Enjoy complimentary customisation on priority with our Enterprise License!
The epilepsy drugs market size has the potential to grow by USD 2.13 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by type (narrow-spectrum drugs and broad-spectrum drugs), etiology (genetic etiology, structural etiology, metabolic etiology, immune etiology, infectious etiology, and unknown etiology), age of onset (neonatal/infantile, childhood, adolescents/adults, and variable age), and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including Abbott Laboratories, Eisai Co. Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Mylan NV, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and UCB SA.
Browse TOC and LoE with selected illustrations and example pages of Epilepsy Drugs Market
The epilepsy drugs market is fragmented. Abbott Laboratories, Eisai Co. Ltd., GlaxoSmithKline Plc, and Johnson & Johnson are some of the major market participants. Factors such as the increasing prevalence of epilepsy, the growing use of specific and sensitive diagnostic modalities, and the rising patient awareness will offer immense growth opportunities. However, low safety profile of antiepileptic drugs, diverse epilepsy syndromes, and lack of cohesive care may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this epilepsy drugs market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and offers information on the products offered by various companies. Moreover, this epilepsy drugs market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Type
Segmentation by Etiology
Segmentation by Age of Onset
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.